CHARACTERIZATION OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA ENTERING REMISSION IN A ROMIPLOSTIM BONE MARROW STUDY

被引：0
|
作者：
Janssens, A. [1 ]
Cervinek, L. [2 ]
Tejeda Romero, M. [3 ]
Wang, X. [4 ]
Eisen, M. [4 ]
机构：
[1] Univ Hosp Leuven, Dept Hematol, Campus Gasthuisberg, Leuven, Belgium
[2] Masaryk Univ, Univ Hosp, Brno, Czech Republic
[3] Hosp Juarez Mexico, Mexico City, DF, Mexico
[4] Amgen Inc, Thousand Oaks, CA USA
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P03
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [41] Romiplostim induces rapid platelet response in adult patients with immune thrombocytopenia
    不详
    FORMULARY, 2012, 47 (02) : 53 - 53
  • [42] Romiplostim: A Bridge To Splenectomy In Three Patients With Refractory Immune Thrombocytopenia (ITP)
    Shah, Dhaval
    Rambally, Siayareh
    Mims, Martha
    Udden, Mark M.
    BLOOD, 2013, 122 (21)
  • [43] A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice
    Steurer, Michael
    Quittet, Philippe
    Papadaki, Helen A.
    Selleslag, Dominik
    Viallard, Jean-Francois
    Kaiafa, Georgia
    Janssens, Ann
    Kozak, Tomas
    Wadenvik, Hans
    Schoonen, Marieke
    Belton, Laura
    Kreuzbauer, Georg
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (02) : 112 - 120
  • [44] Results From a Phase IV Open-Label Study Evaluating Changes In Bone Marrow Morphology In Adult Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim Analysis Of The 1-and 2-Year Romiplostim Cohorts
    Janssens, Ann
    Rodeghiero, Francesco
    Anderson, David
    Chong, Beng
    Boda, Zoltan
    Pabinger, Ingrid
    Cervinek, Libor
    Wang, Xuena
    BLOOD, 2013, 122 (21)
  • [45] Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia
    Cines, Douglas B.
    Wasser, Jeffrey
    Rodeghiero, Francesco
    Chong, Beng H.
    Steurer, Michael
    Provan, Drew
    Lyons, Roger
    Garcia-Chavez, Jaime
    Carpenter, Nancy
    Wang, Xuena
    Eisen, Melissa
    HAEMATOLOGICA, 2017, 102 (08) : 1342 - 1351
  • [46] EFFICACY AND SAFETY OF ROMIPLOSTIM IN PATIENTS ≥65 YEARS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Michel, M.
    Wasser, J.
    Godeau, B.
    Aledort, L.
    Cooper, N.
    Tomiyama, Y.
    Khellaf, M.
    Wang, X.
    Woodard, P.
    HAEMATOLOGICA, 2013, 98 : 196 - 196
  • [47] Efficacy and safety of biosimilar romiplostim in Indian patients with chronic immune thrombocytopenia: A multicentric retrospective study
    Iqbal, Asif
    Sharma, Chandana
    Bora, Roslin L.
    Phukan, Abhijit
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2023, 66 (01) : 96 - 100
  • [48] FLOW CYTOMETRY ANALYSIS OF BONE MARROW HEMATOPOIESIS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Shubinsky, G.
    Kapelushnik, Y.
    Abu-Koider, A.
    Pikovsky, O.
    Gershberg, T.
    Dulman, I.
    Levi, I.
    HAEMATOLOGICA, 2015, 100 : 768 - 768
  • [49] Abnormal Microenvironment of Bone Marrow B Lymphocytes in Patients with Primary Immune Thrombocytopenia
    Yu, Tianshu
    Hou, Ming
    Liu, Xinguang
    Han, Panpan
    BLOOD, 2018, 132
  • [50] A Final Analysis of a Phase 2, Single-Arm Study of Platelet (Plt) Responses and Remission Rates in Patients with Immune Thrombocytopenia (ITP) Receiving Romiplostim
    Newland, Adrian
    Godeau, Bertrand
    Priego, Victor
    Viallard, Jean-Francois
    Fernandez, Maria Fernanda Lopez
    Orejudos, Amelia
    Lopez, Angela
    BLOOD, 2014, 124 (21)
12345